Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Payables (2016 - 2025)

Marimed (MRMD) has disclosed Payables for 15 consecutive years, with $17.1 million as the latest value for Q4 2025.

  • Quarterly Payables fell 6.42% to $17.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.1 million through Dec 2025, down 6.42% year-over-year, with the annual reading at $17.1 million for FY2025, 6.42% down from the prior year.
  • Payables for Q4 2025 was $17.1 million at Marimed, up from $13.6 million in the prior quarter.
  • The five-year high for Payables was $18.8 million in Q1 2025, with the low at $4.8 million in Q1 2023.
  • Average Payables over 5 years is $10.7 million, with a median of $9.2 million recorded in 2023.
  • The sharpest move saw Payables crashed 75.91% in 2021, then skyrocketed 137.67% in 2024.
  • Over 5 years, Payables stood at $6.5 million in 2021, then soared by 59.78% to $10.4 million in 2022, then fell by 6.5% to $9.7 million in 2023, then soared by 88.35% to $18.3 million in 2024, then dropped by 6.42% to $17.1 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $17.1 million, $13.6 million, and $14.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.